nad+ glp-1 NAD GLP Premier - GLP-1 and NAD+

These age-related risks also must be balanced against the cardiovascular risk reduction associated with GLP-1RA use

This means that comparing yourself to them can set you up for varying degrees of frustration and disappointment

Endocrinology 140: 244250, 1999 [DOI] [PubMed] [Google Scholar] 26

COMPARATIVE EFFECTIVENESS IN DKD Cardiovascular-kidney-metabolic traits The choice between SGLT2 inhibitors and GLP-1 receptor agonists for managing DKD should be guided by a comprehensive assessment of an individuals cardiovascular-kidney-metabolic (CKM) health [83]

Typical side effects include nausea, fullness, constipation, or fatigue, which can generally be remedied by timing your meals, staying hydrated, and increasing your fiber

I really am interested in your view!